The International Conference on Health Policy Statistics promotes statistical innovation and collaboration to improve health policy decision-making and population health outcomes.
Policy-driven data analysis, health economics, causal inference, Bayesian methods, predictive modeling, public health data, keynote speeches, panel discussions, workshops, healthcare disparities, statistical methodology, and networking.
1.
Global inequalities found in cancer research funding
2.
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC
3.
Review looks at potential treatment targets in the tumor microenvironment.
4.
Accurately identified high-grade prostate cancer through urine testing.
5.
Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.
1.
Ticagrelor Monotherapy vs. Ticagrelor + Aspirin in ACS Post-PCI: ULTIMATE-DAPT Trial
2.
AI-Driven Chemotherapy: Transforming Cancer Care with Precision and Efficiency
3.
Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics
4.
Epigenetics and Resistance: Mechanisms in Histone Methylation-Targeted Therapies
5.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A New Era in Managing Cancer-Associated Thrombosis
2.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
3.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
Efficient Management of First line ALK-rearranged NSCLC - Part III
5.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
Recommended News For You
1.
Is global cancer care losing its human touch?
2.
Survivors of childhood brain cancer are more likely to be held back in school
3.
Products for Intimate Care and Cancer; Boost for Colorectal Cancer Stool Tests; Ultrasonic Biopsy?
4.
From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.
5.
Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity
Conferences That Might Interest You
Recommended Articles For You
1.
Liquid Biopsy in SCLC: cfDNA Profiling for Diagnosis and Treatment Monitoring
2.
Exploring The Causes and Consequences of Low Transferrin Saturation
3.
Unlocking the Potential of Palbociclib: A Comprehensive Overview
4.
Is AI The New Radiologist For Breast MRI?
5.
Case Study: Advancing Preclinical Oncology Drug Development with Quantitative Systems Pharmacology
Boost Your Knowledge With These Quizzes
1.
Quiz On Infant Chronic Diseases
2.
Quiz on UTI Treatment Options in Men: How Well Do You Know Effective Management Strategies?
3.
Quiz on Ectopic Pregnancy, Causes and Treatment
4.
Quiz on Nerve Conduction: How Sharp Are Your Insights into Neural Function?
5.
Quiz on Tumor Markers in Testicular Cancer: Key Tools for Monitoring and Management
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation